Retatrutide 10mg
A comprehensive guide to safely reconstitute, dose, and administer Retatrutide 10mg. This higher-concentration triple-agonist peptide targets GLP-1, GIP, and glucagon receptors for advanced metabolic support.
Important Legal Disclaimer
This information is for educational and research purposes only. Retatrutide is an investigational peptide and is NOT approved by the FDA for public use. The information provided is based on clinical trial data and research protocols.
Use of this product should ONLY be undertaken under the direct guidance and supervision of a qualified healthcare professional. HHS Pharmaceutical and its affiliates are not liable for any misuse, adverse effects, or outcomes resulting from the use of this information or product.
What is Retatrutide?
Retatrutide is a novel, investigational triple-agonist peptide that activates three key hormone receptors involved in metabolism:
- GLP-1 (Glucagon-Like Peptide-1): Regulates appetite and insulin secretion
- GIP (Glucose-Dependent Insulinotropic Polypeptide): Improves blood sugar control
- Glucagon Receptor: Increases energy expenditure
The 10mg concentration provides a higher dose option for individuals requiring more advanced metabolic support as part of their treatment protocol.
Who Should Use Retatrutide?
Retatrutide 10mg is typically prescribed for individuals with:
- Advanced metabolic dysfunction requiring higher doses
- Progressive dose escalation from lower concentrations
- Need for maintenance doses above 5mg weekly
⚠️ This product should ONLY be used under medical supervision
Always consult with a qualified healthcare professional before beginning any peptide protocol.
Required Supplies
Gather these sterile supplies before beginning:
✓ Retatrutide 10mg Vial
Lyophilized (freeze-dried) powder
✓ Bacteriostatic (BAC) Water
Contains 0.9% benzyl alcohol as preservative
✓ Reconstitution Syringe
1-3mL syringe with 21-23 gauge needle
✓ Administration Syringe
Insulin syringe (0.5-1mL, U-100, 29-31G)
✓ Alcohol Prep Pads
For sterilizing vials and injection sites
✓ Sharps Container
FDA-cleared, puncture-proof disposal
Storage Requirements
Before Reconstitution (Powder)
•Long-term: Freeze at -20°C (-4°F) or below for maximum stability
•Short-term: Refrigerate at 2-8°C (36-46°F)
•Protection: Keep in original packaging, protect from light and moisture
After Reconstitution (Liquid)
•Temperature: Refrigerate at 2-8°C (36-46°F) immediately
•Stability: Stable for up to 30 days (14-21 days recommended)
✗DO NOT FREEZE: Freezing will damage the peptide structure
•Label: Mark vial with reconstitution date
How to Reconstitute
Important: Maintain Sterility Throughout
Follow these steps carefully to preserve peptide integrity and prevent contamination.
Preparation
Allow vials to reach room temperature. Clean hands and work surface. Wipe rubber stoppers with alcohol pads and let air dry.
Draw BAC Water
Using reconstitution syringe, inject air into BAC water vial, then draw desired volume.
Add Water to Vial
Angle needle to touch inner glass wall. DO NOT inject directly onto powder - let water run down the side slowly.
Dissolve Gently
DO NOT SHAKE. Gently swirl or roll vial between palms until completely clear. Discard if cloudy or contains particles.
Label and Refrigerate
Label with reconstitution date and concentration. Store immediately in refrigerator.
Concentration Examples (10mg Vial)
| BAC Water Added | Final Concentration | Volume for 1mg Dose |
|---|---|---|
| 1.0 mL | 10 mg/mL | 0.10 mL (10 units) |
| 2.0 mL | 5 mg/mL | 0.20 mL (20 units) |
| 4.0 mL | 2.5 mg/mL | 0.40 mL (40 units) |
* Calculations based on U-100 insulin syringe (100 units = 1 mL)
Administration (Subcutaneous Injection)
Retatrutide is administered as a once-weekly subcutaneous injection into the fatty tissue just under the skin.
Select and Clean Site
Choose injection site: abdomen (2+ inches from navel), front thigh, or back of upper arm.
✓ Rotate sites with each injection to prevent skin issues
Prepare Dose
Using sterile insulin syringe, draw calculated dose from refrigerated vial.
Pinch Skin
Gently pinch 1-2 inch fold of skin and fat at injection site.
Insert Needle
Insert at 90° angle (45° if low body fat) in one quick, smooth motion.
Inject & Withdraw
Slowly push plunger over 5-10 seconds. Wait 5 seconds, then withdraw needle straight out.
Dispose Safely
Immediately place used syringe in sharps container. Do not recap needle.
Dosing Schedule
Clinical trials use a gradual dose-escalation strategy to improve tolerability and minimize side effects.
Example Titration Schedule
Starting Dose: 1 mg once weekly (to assess individual tolerance)
Escalation: Increase every 4 weeks (e.g., 1mg → 2mg → 4mg → 8mg → 10mg)
Maintenance Range: Typically 4–8 mg once weekly, guided by healthcare provider
⚕️ Medical Supervision Required
Your specific dosing protocol must be determined by a qualified healthcare professional based on your individual needs and response.
Potential Side Effects
Side effects are most common when starting treatment or increasing dose. They are typically mild to moderate and often decrease over time.
Common Side Effects
⚠️ Serious Side Effects - Seek Immediate Medical Attention
Severe Abdominal Pain
Pain radiating to back with or without vomiting (may indicate pancreatitis)
Allergic Reaction
Swelling of face/lips/tongue/throat, hives, difficulty breathing
Gallbladder Disease
Severe right-upper-abdominal pain or jaundice (yellowing of skin/eyes)
When NOT to Use (Contraindications)
DO NOT Use Retatrutide If You Have:
Important Warnings
⚠️ Hypoglycemia Risk (Low Blood Sugar)
Risk increases when used with insulin or sulfonylureas. Monitor blood glucose closely.
⚠️ Drug Interactions
Retatrutide slows stomach emptying, which may affect absorption of oral medications. Inform your healthcare provider of all medications you take.
Always Consult a Healthcare Professional
This guide is for informational purposes only. Proper medical supervision ensures safe and effective use tailored to your individual needs.
View All Products